{"id":"NCT00328263","sponsor":"Bio-K Plus International Inc.","briefTitle":"Efficacy and Safety of BIO-K + CL1285 in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adult Patients","officialTitle":"A Double-blind, Randomized, Placebo Controlled, Multicenter Study of the Efficacy and Safety of BIO-K*+ CL-1285* in the Prevention of Antibiotic-associated Diarrhea in Adult Patients Exposed to Nosocomial Infection.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-03","primaryCompletion":"2007-03","completion":"2007-10","firstPosted":"2006-05-19","resultsPosted":"2014-08-07","lastUpdate":"2014-08-07"},"enrollment":472,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Diarrhea","Clostridium Infections"],"interventions":[{"type":"DIETARY_SUPPLEMENT","name":"Lactobacillus acidophilus CL1285 and Lactobacillus casei","otherNames":["BioK CL1285"]},{"type":"DIETARY_SUPPLEMENT","name":"placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of Bio-K + CL1285 versus placebo in the prevention of antibiotic-associated diarrhea in hospitalized adult patients.","primaryOutcome":{"measure":"The Incidence of Antibiotic-associated Diarrhea.","timeFrame":"Up to 40 days","effectByArm":[{"arm":"Bio-K+ CL1285","deltaMin":216,"sd":null},{"arm":"Placebo","deltaMin":221,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":14},"locations":{"siteCount":8,"countries":["Canada"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":15,"n":216},"commonTop":["Other adverse events","Gastrointestinal adverse events"]}}